Shilpa Medicare cash flow

Latest FY26

Cash from operations: ₹342cr+158.9% on FY25
Capital spending: ₹371cr+52.1% on FY25
Free cash flow: −₹28.5cr−₹111 cr in FY25
Cash from financing: ₹13.6cr−78.3% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	120	113	108	95.5
	—	0.0	1.0	0.0	0.0
	—	47.7	75.5	91.8	0.0
	—	−0.7	−8.0	−1.4	−1.0
	—	0.0	−0.1	0.0	0.0
	—	−28.5	−4.3	−0.9	0.0
	—	4.2	−21.7	3.6	53.7
	—	0.0	0.0	0.0	−3.8
	—	−37.0	−22.3	−25.1	35.4
	—	−66.5	−55.4	−75.9	65.1
	—	0.0	0.0	0.0	44.3
	—	4.8	0.0	−10.4	0.0
	—	0.0	−45.0	0.0	0.0
	—	34.7	−69.4	34.3	−2.3
	—	0.0	54.5	0.0	0.0
	—	28.9	0.0	0.0	6.2
	—	0.0	54.5	−6.6	0.0
Cash from operating activities
	338	295	124	59.1	−34.5
	—	107	72.3	117	293
	—	403	196	176	259
	—	0.0	−16.7	0.0	0.0
	—	60.4	47.0	41.2	32.4
	—	342	132	135	226
Cash from investing activities
	—	371	244	185	273
	—	0.0	0.0	12.1	1.2
	—	0.0	27.5	0.0	0.0
	—	13.3	0.0	0.0	0.0
	—	18.9	0.0	0.0	0.0
	—	49.7	0.0	0.0	0.0
	—	0.0	8.1	0.0	0.0
	—	0.0	0.0	11.0	0.0
	—	0.0	0.0	0.0	0.5
	—	0.7	8.1	1.4	1.3
	—	0.0	0.9	−6.5	−8.9
	—	−326	−199	−167	−278
Cash from financing activities
	—	0.0	489	0.0	0.0
	—	105	−349	140	114
	—	33.2	0.0	0.0	0.0
	—	0.6	0.6	0.5	0.0
	—	—	—	0.0	0.5
	—	47.6	76.7	92.4	57.9
	—	9.8	0.0	0.0	9.5
	—	13.6	62.7	46.8	45.8
	—	29.9	−4.3	15.5	−6.5
	—	−13.3	0.0	−4.2	0.0
	—	16.6	−4.3	11.4	−6.5
	—	—	—	30.4	18.8
Reference items
	479	435	317	244	102
	28.4%	28.3%	24.7%	21.2%	9.7%
	−28.5	−28.5	−111	−49.2	−46.4
	—	−4.4	−537	−1.7	—
	−₹1.45	−₹1.45	−₹5.70	−₹2.52	−₹2.37
	—	1.41×	1.69×	4.25×	−6.96×
	—	60.4	47.0	41.2	32.4
	—	47.6	76.7	92.4	57.9

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SHILPAMED₹935.60

Shilpa Medicare Ltd.

· Pharma & Health

₹ CrorePeersNATCOPHARM SPARC STAR RUBICON SUPRIYA THYROCARE VIYASH PARKHOSPSMcap ₹18,300 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	95.5	107.9	113.0	119.7	—
+ Impairment Loss / (Reversal)	0.0	0.0	1.0	0.0	—
+ Finance Costs	0.0	91.8	75.5	47.7	—
+ Interest Income	-1.0	-1.4	-8.0	-0.7	—
+ Fair Value (Gains) / Losses	0.0	0.0	-0.1	0.0	—
+ Unrealised FX (Gain) / Loss	0.0	-0.9	-4.3	-28.5	—
+ Other Non-cash Items	53.7	3.6	-21.7	4.2	—
+ Other Reconciling Items	-3.8	0.0	0.0	0.0	—
Changes in Working Capital
+ Inventories	35.4	-25.1	-22.3	-37.0	—
+ Trade Receivables — Current	65.1	-75.9	-55.4	-66.5	—
+ Other Financial Assets — Current	44.3	0.0	0.0	0.0	—
+ Other Current Assets	0.0	-10.4	0.0	4.8	—
+ Other Non-current Assets	0.0	0.0	-45.0	0.0	—
+ Trade Payables — Current	-2.3	34.3	-69.4	34.7	—
+ Other Financial Liabilities — Current	0.0	0.0	54.5	0.0	—
+ Other Current Liabilities	6.2	0.0	0.0	28.9	—
+ Other Non-current Liabilities	0.0	-6.6	54.5	0.0	—
Cash from Operating Activities
Profit Before Tax (per I/S)	-34.5	59.1	123.6	295.3	338.3
+ Total Adjustments (incl. Working Capital)	293.0	117.4	72.3	107.3	—
Cash from Operations (pre-tax)	258.5	176.5	195.9	402.6	—
+ Other Inflows / (Outflows) — Operating	0.0	0.0	-16.7	0.0	—
+ Income Taxes Paid	32.4	41.2	47.0	60.4	—
Cash from Operating Activities	226.2	135.3	132.2	342.2	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	272.5	184.6	243.6	370.6	—
+ Disp of Fixed Assets	1.2	12.1	0.0	0.0	—
+ Disp of Investment Property	0.0	0.0	27.5	0.0	—
+ Disp of Other Long-term Assets	0.0	0.0	0.0	13.3	—
+ Purchase of Investments (Equity / Debt)	0.0	0.0	0.0	18.9	—
+ Sale of Investments (Equity / Debt)	0.0	0.0	0.0	49.7	—
+ Disp of Interests in Joint Ventures	0.0	0.0	8.1	0.0	—
+ Disp of Subsidiaries / Businesses (net)	0.0	11.0	0.0	0.0	—
+ Dividends Received — Investing	0.5	0.0	0.0	0.0	—
+ Interest Received — Investing	1.3	1.4	8.1	0.7	—
+ Other Inflows / (Outflows) — Investing	-8.9	-6.5	0.9	0.0	—
Cash from Investing Activities	-278.5	-166.6	-199.1	-325.9	—
Cash from Financing Activities
+ Proceeds from Issue of Shares	0.0	0.0	489.1	0.0	—
+ Proceeds from Borrowings	113.8	139.7	-349.2	104.8	—
+ Repayment of Borrowings	0.0	0.0	0.0	33.2	—
+ Payment of Lease Liabilities	0.0	0.5	0.6	0.6	—
+ Payment of Finance Lease Liabilities	0.5	0.0	—	—	—
+ Interest Paid	57.9	92.4	76.7	47.6	—
+ Dividends Paid	9.5	0.0	0.0	9.8	—
Cash from Financing Activities	45.8	46.8	62.7	13.6	—
Net Changes in Cash (pre-FX)	-6.5	15.5	-4.3	29.9	—
+ Effect of FX Rate Changes on Cash	0.0	-4.2	0.0	-13.3	—
Net Changes in Cash	-6.5	11.4	-4.3	16.6	—
Closing Cash	18.8	30.4	—	—	—
Reference Items
EBITDA	102.3	244.5	317.0	434.7	478.6
EBITDA Margin %	9.74	21.23	24.65	28.25	28.44
Free Cash Flow (CFO − Capex)	-46.4	-49.2	-111.5	-28.5	-28.5
Free Cash Flow to Equity	—	-1.7	-537.4	-4.4	—
Free Cash Flow per Basic Share	-2.37	-2.52	-5.70	-1.45	-1.45
Cash Flow to Net Income	-6.96	4.25	1.69	1.41	—
Cash Paid for Taxes	32.4	41.2	47.0	60.4	—
Cash Paid for Interest	57.9	92.4	76.7	47.6	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.